|
Insider Trading: Xtent Inc
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Xtent Inc in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of Xtent Inc since year 2005. Table 2 shows the detailed insider transactions of Xtent Inc since 2005.
The reporting company's ticker symbol is XTNT.
The reporting company's CIK number is 1212235.
The total value of stock buying since 2005 is $432,000.
The total value of stock sales is $674,547.
The total value of stock exercises is $11,000.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at Xtent Inc (XTNT) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 09 10 -
Figure 2. Average prices of insider buys, sales, and option exercises at Xtent Inc (XTNT) in the past 24 months. See table 2 for insider transaction details.
11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 09 10 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for Xtent Inc (XTNT).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2008-10 | 0 | 0 | 5,000 | 6,680 | 0 | 0 |
| 2008-09 | 0 | 0 | 5,000 | 10,100 | 0 | 0 |
| 2008-08 | 0 | 0 | 3,500 | 8,967 | 0 | 0 |
| 2008-07 | 0 | 0 | 3,500 | 8,505 | 10,000 | 4,000 |
| 2008-06 | 0 | 0 | 3,500 | 12,127 | 0 | 0 |
| 2008-05 | 0 | 0 | 3,500 | 12,250 | 0 | 0 |
| 2008-04 | 0 | 0 | 17,500 | 83,477 | 1,000 | 3,500 |
| 2008-03 | 0 | 0 | 11,500 | 81,266 | 1,000 | 3,500 |
| 2008-02 | 0 | 0 | 10,500 | 101,078 | 0 | 0 |
| 2008-01 | 0 | 0 | 14,000 | 138,402 | 0 | 0 |
| 2007-12 | 0 | 0 | 5,200 | 48,983 | 0 | 0 |
| 2007-11 | 0 | 0 | 7,000 | 70,057 | 0 | 0 |
| 2007-10 | 0 | 0 | 7,000 | 64,802 | 0 | 0 |
| 2007-09 | 0 | 0 | 3,500 | 27,853 | 0 | 0 |
| 2007-02 | 27,000 | 432,000 | 0 | 0 | 0 | 0 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for Xtent Inc (XTNT)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-10-01 | Marco Philippe H (VP-QA, Clinical & Reg. Affairs) | Sale | 5,000 | 1.34 | 6,680 |
| 2008-09-02 | Marco Philippe H (VP-QA, Clinical & Reg. Affairs) | Sale | 5,000 | 2.02 | 10,100 |
| 2008-08-01 | Marco Philippe H (VP-QA, Clinical & Reg. Affairs) | Sale | 3,500 | 2.56 | 8,967 |
| 2008-07-18 | Walsh Brian J (Other) | Option Exercise | 10,000 | .40 | 4,000 |
| 2008-07-01 | Marco Philippe H (VP-QA, Clinical & Reg. Affairs) | Sale | 3,500 | 2.43 | 8,505 |
| 2008-06-02 | Marco Philippe H (VP-QA, Clinical & Reg. Affairs) | Sale | 3,500 | 3.46 | 12,127 |
| 2008-05-01 | Marco Philippe H (VP-QA, Clinical & Reg. Affairs) | Sale | 3,500 | 3.50 | 12,250 |
| 2008-04-24 | Walsh Brian J (VP-Sales & Marketing) | Sale | 3,000 | 4.12 | 12,375 |
| 2008-04-23 | Walsh Brian J (VP-Sales & Marketing) | Sale | 3,000 | 4.55 | 13,657 |
| 2008-04-02 | Grainger Jeffry J (VP-Corp Affairs & Gen. Counsel) | Sale | 3,000 | 4.94 | 14,820 |
| 2008-04-01 | Kahlenberg Timothy D (Chief Financial Officer) | Sale | 1,000 | 5.02 | 5,025 |
| 2008-04-01 | Kahlenberg Timothy D (Chief Financial Officer) | Option Exercise | 1,000 | 3.50 | 3,500 |
| 2008-04-01 | Marco Philippe H (VP-QA, Clinical & Reg. Affairs) | Sale | 3,500 | 5.00 | 17,500 |
| 2008-04-01 | Grainger Jeffry J (VP-Corp Affairs & Gen. Counsel) | Sale | 2,000 | 5.02 | 10,050 |
| 2008-04-01 | Casciaro Gregory D (President and CEO) | Sale | 2,000 | 5.02 | 10,050 |
| 2008-03-03 | Kahlenberg Timothy D (Chief Financial Officer) | Sale | 1,000 | 7.11 | 7,113 |
| 2008-03-03 | Kahlenberg Timothy D (Chief Financial Officer) | Option Exercise | 1,000 | 3.50 | 3,500 |
| 2008-03-03 | Marco Philippe H (VP-QA, Clinical & Reg. Affairs) | Sale | 3,500 | 7.05 | 24,683 |
| 2008-03-03 | Grainger Jeffry J (VP-Corp Affairs & Gen. Counsel) | Sale | 5,000 | 7.07 | 35,336 |
| 2008-03-03 | Casciaro Gregory D (President and CEO) | Sale | 2,000 | 7.07 | 14,134 |
| 2008-02-04 | Casciaro Gregory D (President and CEO) | Sale | 2,000 | 9.78 | 19,550 |
| 2008-02-01 | Marco Philippe H (VP-QA, Clinical & Reg. Affairs) | Sale | 3,500 | 9.65 | 33,778 |
| 2008-02-01 | Grainger Jeffry J (VP-Corp Affairs & Gen. Counsel) | Sale | 5,000 | 9.55 | 47,750 |
| 2008-01-25 | Marco Philippe H (VP-QA, Clinical & Reg. Affairs) | Sale | 7,000 | 10.02 | 70,154 |
| 2008-01-03 | Marco Philippe H (VP-QA, Clinical & Reg. Affairs) | Sale | 1,400 | 9.11 | 12,749 |
| 2008-01-02 | Marco Philippe H (VP-QA, Clinical & Reg. Affairs) | Sale | 2,100 | 9.72 | 20,422 |
| 2007-12-26 | Marco Philippe H (VP-QA, Clinical & Reg. Affairs) | Sale | 1,700 | 10.00 | 17,000 |
| 2007-12-06 | Marco Philippe H (VP-QA, Clinical & Reg. Affairs) | Sale | 3,500 | 9.14 | 31,983 |
| 2007-11-01 | Marco Philippe H (VP-QA, Clinical & Reg. Affairs) | Sale | 7,000 | 10.01 | 70,057 |
| 2007-10-18 | Marco Philippe H (VP-QA, Clinical & Reg. Affairs) | Sale | 3,500 | 10.01 | 35,035 |
| 2007-10-01 | Marco Philippe H (VP-QA, Clinical & Reg. Affairs) | Sale | 3,500 | 8.50 | 29,767 |
| 2007-09-04 | Marco Philippe H (VP-QA, Clinical & Reg. Affairs) | Sale | 3,500 | 7.96 | 27,853 |
| 2007-02-06 | Bellas Robert C Jr (Director) | Purchase | 25,000 | 16.00 | 400,000 |
| 2007-02-06 | Flaherty Robert E (Director) | Purchase | 2,000 | 16.00 | 32,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Xtent Inc (symbol XTNT,
CIK number 1212235) see
the Securities and Exchange Commission (SEC) website.
|
|
